Retatrutide 5mg (Bacteriostatic water not included)

💉 Retatrutide (5 mg)

Retatrutide is an investigational (not yet FDA-approved) medication being studied for obesity and type 2 diabetes. It’s currently in clinical trials and not commercially available through regular pharmacies.

🔬 How It Works (Triple Agonist)

Retatrutide activates three receptors:

• GLP-1 → reduces appetite, slows digestion

• GIP → improves insulin response and metabolic efficiency

• Glucagon → increases energy expenditure (burns more calories)

That third mechanism (glucagon activation) is what separates it from:

• Semaglutide

• Tirzepatide

Retatrutide potentially increases both appetite control and metabolic rate.

📦 What “5 mg” Means

In clinical trials, dosing is gradually increased to reduce side effects.

5 mg would generally be considered a mid-range titration dose, depending on the protocol being followed.

Because it is still experimental:

• There is no standardized public dosing protocol

• Long-term safety data is still being collected

• Products outside clinical trials are unregulated

📊 Reported Trial Results

In Phase 2 studies:

• Up to 24%+ body weight reduction

• Significant fat mass loss

• Improved blood sugar control

• Noticeable waist circumference reduction

These results were among the strongest seen in weight-loss medications to date.

⚠️ Common Side Effects

• Nausea

• Vomiting

• Diarrhea

• Strong appetite suppression

• Elevated heart rate (due to glucagon activity)

Side effects tend to increase as dosage increases.

Retatrutide 10mg (Bacteriostatic water not included)